Cargando…

The Chk1 inhibitor MK-8776 increases the radiosensitivity of human triple-negative breast cancer by inhibiting autophagy

MK-8776 is a recently described inhibitor that is highly selective for checkpoint kinase 1 (Chk1), which can weaken the DNA repair capacity in cancer cells to achieve chemo-sensitization. A number of studies show that MK-8776 enhances the cytotoxicity of hydroxyurea and gemcitabine without increasin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Zhi-rui, Yang, Zhao-zhi, Wang, Shao-jia, Zhang, Li, Luo, Ju-rui, Feng, Yan, Yu, Xiao-li, Chen, Xing-xing, Guo, Xiao-mao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386307/ https://www.ncbi.nlm.nih.gov/pubmed/28042876 http://dx.doi.org/10.1038/aps.2016.136

Ejemplares similares

MK-8776, a novel chk1 kinase inhibitor, radiosensitizes p53-defective human tumor cells
por: Bridges, Kathleen A., et al.
Publicado: (2016)

Chk1 Inhibitor MK-8776 Restores the Sensitivity of Chemotherapeutics in P-glycoprotein Overexpressing Cancer Cells
por: Cui, Qingbin, et al.
Publicado: (2019)

MK-8776, a novel Chk1 inhibitor, exhibits an improved radiosensitizing effect compared to UCN-01 by exacerbating radiation-induced aberrant mitosis
por: Suzuki, Motofumi, et al.
Publicado: (2017)

Sensitization of human cancer cells to gemcitabine by the Chk1 inhibitor MK-8776: cell cycle perturbation and impact of administration schedule in vitro and in vivo
por: Montano, Ryan, et al.
Publicado: (2013)

A subset of cancer cell lines is acutely sensitive to the Chk1 inhibitor MK-8776 as monotherapy due to CDK2 activation in S phase
por: Sakurikar, Nandini, et al.
Publicado: (2015)

Draft Genome Sequence of Corynebacterium sanguinis Strain Marseille-P8776
por: Khare, Mudra, et al.
Publicado: (2022)

EGFR signaling promotes resistance to CHK1 inhibitor prexasertib in triple negative breast cancer
por: Lee, Kevin J., et al.
Publicado: (2020)

Highlights on molecular targets for radiosensitization of breast cancer cells: Current research status and prospects
por: Zhou, Zhi‐Rui, et al.
Publicado: (2018)

CHK1 plays a critical role in the anti-leukemic activity of the wee1 inhibitor MK-1775 in acute myeloid leukemia cells
por: Qi, Wenxiu, et al.
Publicado: (2014)

CHK2 is involved in the p53-independent radiosensitizing effects of valproic acid
por: Choo, Dong Wan, et al.
Publicado: (2017)

Silencing of XRCC4 increases radiosensitivity of triple-negative breast cancer cells
por: Wen, Yuqing, et al.
Publicado: (2019)

Inhibition of Chk1 by miR-320c increases oxaliplatin responsiveness in triple-negative breast cancer
por: Lim, Sera, et al.
Publicado: (2020)

Estrogen Receptor Mediates the Radiosensitivity of Triple-Negative Breast Cancer Cells
por: Chen, Xingxing, et al.
Publicado: (2017)

Chk1 Inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers
por: Bryant, Christopher, et al.
Publicado: (2014)

Combating CHK1 resistance in triple negative breast cancer: EGFR inhibition as potential combinational therapy
por: Stefanski, Casey D., et al.
Publicado: (2022)

Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells
por: Swanner, Jessica, et al.
Publicado: (2015)

Trifluoperazine, a novel autophagy inhibitor, increases radiosensitivity in glioblastoma by impairing homologous recombination
por: Zhang, Xin, et al.
Publicado: (2017)

Autophagy and radiosensitization in cancer
por: Sharma, Khushboo, et al.
Publicado: (2014)

Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cells
por: Bridges, Kathleen A., et al.
Publicado: (2014)

CHK2 Promotes Metabolic Stress-Induced Autophagy through ULK1 Phosphorylation
por: Guo, Ran, et al.
Publicado: (2022)

Radiosensitization with combined use of olaparib and PI-103 in triple-negative breast cancer
por: Jang, Na Young, et al.
Publicado: (2015)

Keeping RelApse in Chk: molecular mechanisms of Chk1 inhibitor resistance in lymphoma
por: Black, Elizabeth M., et al.
Publicado: (2022)

Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivo
por: Zhao, Yuan-Yuan, et al.
Publicado: (2014)

Chk-mate on resistance to kinase inhibitors
por: Shapiro, Paul
Publicado: (2018)

HDAC6 Regulates Radiosensitivity of Non-Small Cell Lung Cancer by Promoting Degradation of Chk1
por: Moses, Niko, et al.
Publicado: (2020)

Hypoxia-targeted triple suicide gene therapy radiosensitizes human colorectal cancer cells
por: HSIAO, HUNG TSUNG, et al.
Publicado: (2014)

Mechanism and clinical value of exosomes and exosomal contents in regulating solid tumor radiosensitivity
por: Sun, Huihui, et al.
Publicado: (2022)

CHK2-FOXK axis promotes transcriptional control of autophagy programs
por: Chen, Yuping, et al.
Publicado: (2020)

Chk1, Chk2, is the amplifier on?
por: Dove, Alan W.
Publicado: (2001)

Tumour growth environment modulates Chk1 signalling pathways and Chk1 inhibitor sensitivity
por: Massey, Andrew J.
Publicado: (2016)

BRD7 suppresses tumor chemosensitivity to CHK1 inhibitors by inhibiting USP1-mediated deubiquitination of CHK1
por: Li, Lemin, et al.
Publicado: (2023)

The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus
por: Vázquez, Ramiro, et al.
Publicado: (2016)

Chloroquine, an autophagy inhibitor, potentiates the radiosensitivity of glioma initiating cells by inhibiting autophagy and activating apoptosis
por: Ye, Hongxing, et al.
Publicado: (2016)

Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer
por: Bennett, Christina N, et al.
Publicado: (2012)

Downregulation of CDC20 Increases Radiosensitivity through Mcl-1/p-Chk1-Mediated DNA Damage and Apoptosis in Tumor Cells
por: Gao, Yang, et al.
Publicado: (2020)

The MRN complex maintains the biliary-derived hepatocytes in liver regeneration through ATR-Chk1 pathway
por: Song, Jingmei, et al.
Publicado: (2023)

Conceptualizing the complexity of ferroptosis to treat triple-negative breast cancer: theory-to-practice
por: Zhang, Hang, et al.
Publicado: (2023)

Chk2 Regulates Cell Cycle Progression during Mouse Oocyte Maturation and Early Embryo Development
por: Dai, Xiao-Xin, et al.
Publicado: (2014)

Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia
por: Rorà, Andrea Ghelli Luserna Di, et al.
Publicado: (2016)

Signaling of MK2 sustains robust AP1 activity for triple negative breast cancer tumorigenesis through direct phosphorylation of JAB1
por: Chen, Haoming, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1ooi7340dl6nlhn73gniv2op23